ALX Oncology Holdings Inc.ALXONASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank100
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-0.60
↑ 97% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthElevated
Average
-22.07
Historical baseline
PeriodValueYoY Change
2025-0.60+7.7%
2024-0.65+83.8%
2023-3.98-7.2%
2022-3.71+64.2%
2021-10.38+86.2%
2020-75.09-119.4%
2019-34.22+28.6%
2018-47.96-